Answers are grounded in this paper and cite their sources.
Evaluates nutritional and antioxidant properties of Moringa-Bambara-maize composites, indicating potential health benefits.
This study evaluated composite flours formulated from Moringa oleifera leaf powder (8.07–11.24%), Bambara groundnut (23%), and yellow maize (45–61%) for their nutritional, antioxidant, and glycemic-modulating properties. The composites exhibited enhanced protein (16.23–17.57%), fibre (2.70–3.24%), and ash (2.92–3.77%). The pasting properties of the composites indicating improved paste stability and reduced retrogradation, characteristics favourable for reconstitutable and processed food applications. Bioactive compounds were significantly enriched: total phenolics (2.67–2.77 mg GAE/g), flavonoids (1.15–1.28 mg QE/g), and tannins (4.93–5.96 mg/g). Antioxidant activity improved across assays: DPPH SC₅₀ (1.24–4.04 mg/mL), ABTS SC₅₀ (4.29–11.12 mg/mL), and FRAP (2.21–2.46 mmol Fe²+/g). Enzyme inhibition was notable for α-amylase (IC₅₀: 3.47–4.48 mg/mL) and α-glucosidase (1.17–2.05 mg/mL). These results support the potential of Moringa–Bambara–maize composites as nutritionally enriched, functional food ingredients for managing oxidative stress and postprandial glycemia.
No takes yet. Share an insight, caveat, or question.
Elemosho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: